Home
- Questions About Raises, Shuttle Fees Top Administrators Forum
A UAMS Update article about Meet Your Administrator”
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Doughnut Sale to Help UAMS Psychiatry Youth Program
A UAMS Update article about a bake sale
- Call-in Announcements, Forums Will Give Employees More Information
A UAMS Update article about plans to improve communication between administration and employees of UAMS Medical Center
- IT Help Desk 400,000th Call Sweepstakes
IT Help Desk 400,000th Call Sweepstates
- The UAMS Help Desk Today - Ten Years Later
The UAMS Help Desk Today - Ten Years Later
- Free Tickets for UAMS Nights at Ray Winder Field
A UAMS Update article about UAMS Night with the Travelers
- ARIA Training Sessions May 19 - June 27 at UAMS
A UAMS Update article about May 19 - June 27 training sessions
- Human Research Forum Is May 21
A UAMS Update article about human research Q & A
- Accolades, May 2003
Accolades to UAMS faculty and staff
- GCRC Deadline Changed to July 1 for Grant Proposals
A UAMS Update article about GCRC pilot grants
- History of the Help Desk
- Watch, Look & Listen: Preview of New UAMS Public Service Campaign
- Forum to Discuss Impact of HIPAA on Research
Update article about HIPAA and research at UAMS
- Human Research Q and A Forum June 27
A UAMS Update article about the human research forum
- Emailed Version of UAMS Notice of Privacy Practices
UAMS Notice of Privacy Practices
- Free UAF Symposium Aug. 14-15 on Evolution of Human Diet
A UAMS Update article about a diet symposium at UAF
- Tom Butler is Arkansas Administrator of the Year
Tom Butler of UAMS Is Arkansas Administrator of the Year
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
- Kids First in Fort Smith Celebrated Fourth in Style
Kids First in Fort Smith Celebrated Fourth in Style
- Class of 1948 Dedicates Endowment to Excellence in Education
Class of 1948 Dedicates Endowment to Excellence in Education
- Pharmacy Professor Elected to American College of Clinical Pharmacy
Pharmacy Professor Elected to American College of Clinical Pharmacy
- Pharmaceutical Scientists, Graduate Students Meet at UAMS
Pharmaceutical Scientists, Graduate Students Meet at UAMS
- Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
- New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
- Ready, Set, Go! UAMS, KATV Launch Get Healthy Arkansas™
UAMS, KATV Launch Get Healthy Arkansas™
- UAMS Marks Record Number of Stem-Cell Transplants In 2004
JAN. 27, 2005 | More than 630 patients received stem-cell transplants at the University of Arkansas for Medical Sciences (UAMS) in 2004, more than any other facility in the nation and a record for an institution that has performed more of the procedures on cancer patients than any other facility in the world.
- UAMS Marks Record Number of Stem-Cell Transplants In 2004
JAN. 27, 2005 | More than 630 patients received stem-cell transplants at the University of Arkansas for Medical Sciences (UAMS) in 2004, more than any other facility in the nation and a record for an institution that has performed more of the procedures on cancer patients than any other facility in the world.
- UAMS Marks Record Number of Stem-Cell Transplants In 2004
JAN. 27, 2005 | More than 630 patients received stem-cell transplants at the University of Arkansas for Medical Sciences (UAMS) in 2004, more than any other facility in the nation and a record for an institution that has performed more of the procedures on cancer patients than any other facility in the world.
- UAMS Marks Record Number of Stem-Cell Transplants In 2004
JAN. 27, 2005 | More than 630 patients received stem-cell transplants at the University of Arkansas for Medical Sciences (UAMS) in 2004, more than any other facility in the nation and a record for an institution that has performed more of the procedures on cancer patients than any other facility in the world.
- UAMS Marks Record Number of Stem-Cell Transplants In 2004
JAN. 27, 2005 | More than 630 patients received stem-cell transplants at the University of Arkansas for Medical Sciences (UAMS) in 2004, more than any other facility in the nation and a record for an institution that has performed more of the procedures on cancer patients than any other facility in the world.
- Blass Cancer Vaccine Core Laboratory at UAMS Launches Cellular-level Attack on Cancer Cells
APRIL 18, 2005 | The University of Arkansas for Medical Sciences (UAMS) reached another milestone April 13 with the dedication of an immunotherapy laboratory to develop cancer-fighting vaccines.
- Blass Cancer Vaccine Core Laboratory at UAMS Launches Cellular-level Attack on Cancer Cells
APRIL 18, 2005 | The University of Arkansas for Medical Sciences (UAMS) reached another milestone April 13 with the dedication of an immunotherapy laboratory to develop cancer-fighting vaccines.
- Blass Cancer Vaccine Core Laboratory at UAMS Launches Cellular-level Attack on Cancer Cells
APRIL 18, 2005 | The University of Arkansas for Medical Sciences (UAMS) reached another milestone April 13 with the dedication of an immunotherapy laboratory to develop cancer-fighting vaccines.
- Blass Cancer Vaccine Core Laboratory at UAMS Launches Cellular-level Attack on Cancer Cells
APRIL 18, 2005 | The University of Arkansas for Medical Sciences (UAMS) reached another milestone April 13 with the dedication of an immunotherapy laboratory to develop cancer-fighting vaccines.
- Blass Cancer Vaccine Core Laboratory at UAMS Launches Cellular-level Attack on Cancer Cells
APRIL 18, 2005 | The University of Arkansas for Medical Sciences (UAMS) reached another milestone April 13 with the dedication of an immunotherapy laboratory to develop cancer-fighting vaccines.
- NE Journal of Medicine Praises Book Compiled By UAMS Professor
May 3, 2005 | A book by Paulette Mehta, M.D., on pediatric bone marrow stem cell transplants drew enthusiastic praise recently in the prestigious New England Journal of Medicine for filling an important gap in medical literature.
- NE Journal of Medicine Praises Book Compiled By UAMS Professor
May 3, 2005 | A book by Paulette Mehta, M.D., on pediatric bone marrow stem cell transplants drew enthusiastic praise recently in the prestigious New England Journal of Medicine for filling an important gap in medical literature.
- NE Journal of Medicine Praises Book Compiled By UAMS Professor
May 3, 2005 | A book by Paulette Mehta, M.D., on pediatric bone marrow stem cell transplants drew enthusiastic praise recently in the prestigious New England Journal of Medicine for filling an important gap in medical literature.
- NE Journal of Medicine Praises Book Compiled By UAMS Professor
May 3, 2005 | A book by Paulette Mehta, M.D., on pediatric bone marrow stem cell transplants drew enthusiastic praise recently in the prestigious New England Journal of Medicine for filling an important gap in medical literature.
- NE Journal of Medicine Praises Book Compiled By UAMS Professor
May 3, 2005 | A book by Paulette Mehta, M.D., on pediatric bone marrow stem cell transplants drew enthusiastic praise recently in the prestigious New England Journal of Medicine for filling an important gap in medical literature.
- NE Journal of Medicine Praises Book Compiled By UAMS Professor
May 3, 2005 | A book by Paulette Mehta, M.D., on pediatric bone marrow stem cell transplants drew enthusiastic praise recently in the prestigious New England Journal of Medicine for filling an important gap in medical literature.
- NE Journal of Medicine Praises Book Compiled By UAMS Professor
May 3, 2005 | A book by Paulette Mehta, M.D., on pediatric bone marrow stem cell transplants drew enthusiastic praise recently in the prestigious New England Journal of Medicine for filling an important gap in medical literature.
- Virus Shows Anti-Cancer Potential, Says UAMS Researcher
Virus Shows Anti-Cancer Potential, Says UAMS Researcher
Converting Protein Produced by Virus into Treatment Now a Focus
- Virus Shows Anti-Cancer Potential, Says UAMS Researcher
Virus Shows Anti-Cancer Potential, Says UAMS Researcher
Converting Protein Produced by Virus into Treatment Now a Focus
- Virus Shows Anti-Cancer Potential, Says UAMS Researcher
Virus Shows Anti-Cancer Potential, Says UAMS Researcher
Converting Protein Produced by Virus into Treatment Now a Focus
- Virus Shows Anti-Cancer Potential, Says UAMS Researcher
Virus Shows Anti-Cancer Potential, Says UAMS Researcher
Converting Protein Produced by Virus into Treatment Now a Focus
- Study Finds Digital Mammograms Offer Superior Results
LITTLE ROCK — A recently released study funded by the National Cancer Institute (NCI) has confirmed the superiority of digital mammography over film screen mammography in detecting breast cancer, particularly in women younger than 50 and in those with dense breasts. This technology is offered in Little Rock only at the University of Arkansas for Medical Sciences (UAMS).
- Study Finds Digital Mammograms Offer Superior Results
LITTLE ROCK — A recently released study funded by the National Cancer Institute (NCI) has confirmed the superiority of digital mammography over film screen mammography in detecting breast cancer, particularly in women younger than 50 and in those with dense breasts. This technology is offered in Little Rock only at the University of Arkansas for Medical Sciences (UAMS).
- Study Finds Digital Mammograms Offer Superior Results
LITTLE ROCK — A recently released study funded by the National Cancer Institute (NCI) has confirmed the superiority of digital mammography over film screen mammography in detecting breast cancer, particularly in women younger than 50 and in those with dense breasts. This technology is offered in Little Rock only at the University of Arkansas for Medical Sciences (UAMS).
- Study Finds Digital Mammograms Offer Superior Results
LITTLE ROCK — A recently released study funded by the National Cancer Institute (NCI) has confirmed the superiority of digital mammography over film screen mammography in detecting breast cancer, particularly in women younger than 50 and in those with dense breasts. This technology is offered in Little Rock only at the University of Arkansas for Medical Sciences (UAMS).
- Study Finds Digital Mammograms Offer Superior Results
LITTLE ROCK — A recently released study funded by the National Cancer Institute (NCI) has confirmed the superiority of digital mammography over film screen mammography in detecting breast cancer, particularly in women younger than 50 and in those with dense breasts. This technology is offered in Little Rock only at the University of Arkansas for Medical Sciences (UAMS).
- Study Finds Digital Mammograms Offer Superior Results
LITTLE ROCK — A recently released study funded by the National Cancer Institute (NCI) has confirmed the superiority of digital mammography over film screen mammography in detecting breast cancer, particularly in women younger than 50 and in those with dense breasts. This technology is offered in Little Rock only at the University of Arkansas for Medical Sciences (UAMS).
- Breast Cancer Treatment Developed by UAMS Surgeon Shown in Clinical Trial to Reduce Repeat Surgery Following Lumpectompy by 86 Percent
LITTLE ROCK – A breast cancer treatment developed by University of Arkansas for Medical Sciences (UAMS) surgeon V. Suzanne Klimberg, M.D., has been shown in a clinical trial to reduce the need for repeat surgery following lumpectomy by 86 percent.
- Breast Cancer Treatment Developed by UAMS Surgeon Shown in Clinical Trial to Reduce Repeat Surgery Following Lumpectompy by 86 Percent
LITTLE ROCK – A breast cancer treatment developed by University of Arkansas for Medical Sciences (UAMS) surgeon V. Suzanne Klimberg, M.D., has been shown in a clinical trial to reduce the need for repeat surgery following lumpectomy by 86 percent.
- Breast Cancer Treatment Developed by UAMS Surgeon Shown in Clinical Trial to Reduce Repeat Surgery Following Lumpectompy by 86 Percent
LITTLE ROCK – A breast cancer treatment developed by University of Arkansas for Medical Sciences (UAMS) surgeon V. Suzanne Klimberg, M.D., has been shown in a clinical trial to reduce the need for repeat surgery following lumpectomy by 86 percent.
- Breast Cancer Treatment Developed by UAMS Surgeon Shown in Clinical Trial to Reduce Repeat Surgery Following Lumpectompy by 86 Percent
LITTLE ROCK – A breast cancer treatment developed by University of Arkansas for Medical Sciences (UAMS) surgeon V. Suzanne Klimberg, M.D., has been shown in a clinical trial to reduce the need for repeat surgery following lumpectomy by 86 percent.
- Osteoporosis Drug Raloxifene as Effective as Tamoxifen in Preventing Invasive Breast Cancer, Initial Study Results Show
LITTLE ROCK – Initial results of the Study of Tamoxifen and Raloxifene, or STAR, show that the drug raloxifene, currently used to prevent and treat osteoporosis in postmenopausal women, works as well as tamoxifen in reducing breast cancer risk for postmenopausal women at increased risk of the disease. The University of Arkansas for Medical Sciences (UAMS) participated in this clinical trial, one of the largest breast cancer prevention trials ever conducted.
- Osteoporosis Drug Raloxifene as Effective as Tamoxifen in Preventing Invasive Breast Cancer, Initial Study Results Show
LITTLE ROCK – Initial results of the Study of Tamoxifen and Raloxifene, or STAR, show that the drug raloxifene, currently used to prevent and treat osteoporosis in postmenopausal women, works as well as tamoxifen in reducing breast cancer risk for postmenopausal women at increased risk of the disease. The University of Arkansas for Medical Sciences (UAMS) participated in this clinical trial, one of the largest breast cancer prevention trials ever conducted.
- Osteoporosis Drug Raloxifene as Effective as Tamoxifen in Preventing Invasive Breast Cancer, Initial Study Results Show
LITTLE ROCK – Initial results of the Study of Tamoxifen and Raloxifene, or STAR, show that the drug raloxifene, currently used to prevent and treat osteoporosis in postmenopausal women, works as well as tamoxifen in reducing breast cancer risk for postmenopausal women at increased risk of the disease. The University of Arkansas for Medical Sciences (UAMS) participated in this clinical trial, one of the largest breast cancer prevention trials ever conducted.
- Osteoporosis Drug Raloxifene as Effective as Tamoxifen in Preventing Invasive Breast Cancer, Initial Study Results Show
LITTLE ROCK – Initial results of the Study of Tamoxifen and Raloxifene, or STAR, show that the drug raloxifene, currently used to prevent and treat osteoporosis in postmenopausal women, works as well as tamoxifen in reducing breast cancer risk for postmenopausal women at increased risk of the disease. The University of Arkansas for Medical Sciences (UAMS) participated in this clinical trial, one of the largest breast cancer prevention trials ever conducted.
- UAMS Researchers Receive $2.9 Million to Study Novel Breast Cancer Vaccine
LITTLE ROCK — Two researchers at the University of Arkansas for Medical Sciences’ (UAMS) Arkansas Cancer Research Center (ACRC) have received a $2.9 million federal grant to study a new type of vaccine to prevent the recurrence of breast cancer.
Thomas Kieber-Emmons, Ph.D., the Josetta Wilkins Chair of Breast Cancer Research, and Laura Hutchins, M.D., director of the Division of Hematology and Oncology, were awarded the grant to study a carbohydrate-targeting vaccine shown to stimulate the killing of tumor cells.
- UAMS Researchers Receive $2.9 Million to Study Novel Breast Cancer Vaccine
LITTLE ROCK — Two researchers at the University of Arkansas for Medical Sciences’ (UAMS) Arkansas Cancer Research Center (ACRC) have received a $2.9 million federal grant to study a new type of vaccine to prevent the recurrence of breast cancer.
Thomas Kieber-Emmons, Ph.D., the Josetta Wilkins Chair of Breast Cancer Research, and Laura Hutchins, M.D., director of the Division of Hematology and Oncology, were awarded the grant to study a carbohydrate-targeting vaccine shown to stimulate the killing of tumor cells.
- UAMS Researchers Receive $2.9 Million to Study Novel Breast Cancer Vaccine
LITTLE ROCK — Two researchers at the University of Arkansas for Medical Sciences’ (UAMS) Arkansas Cancer Research Center (ACRC) have received a $2.9 million federal grant to study a new type of vaccine to prevent the recurrence of breast cancer.
Thomas Kieber-Emmons, Ph.D., the Josetta Wilkins Chair of Breast Cancer Research, and Laura Hutchins, M.D., director of the Division of Hematology and Oncology, were awarded the grant to study a carbohydrate-targeting vaccine shown to stimulate the killing of tumor cells.
- UAMS Researchers Receive $2.9 Million to Study Novel Breast Cancer Vaccine
LITTLE ROCK — Two researchers at the University of Arkansas for Medical Sciences’ (UAMS) Arkansas Cancer Research Center (ACRC) have received a $2.9 million federal grant to study a new type of vaccine to prevent the recurrence of breast cancer.
Thomas Kieber-Emmons, Ph.D., the Josetta Wilkins Chair of Breast Cancer Research, and Laura Hutchins, M.D., director of the Division of Hematology and Oncology, were awarded the grant to study a carbohydrate-targeting vaccine shown to stimulate the killing of tumor cells.
- ACRC Researchers Publish Papers, Make Presentations
JULY 18, 2006 | The Department of Otolaryngology-Head and Neck Surgery held its 13th Annual J. Floyd Kyser, M.D., Resident Research and Alumni Conference June 9-10. Residents presented their research papers on June 9 in the ACRC Sam Walton Auditorium, and the Chief Residents’ Banquet was held that evening at the Embassy Suites Hotel. George A. Gates, M.D., an emeritus professor in the Department of Otolaryngology-Head and Neck Surgery at the University of Washington in Seattle was the guest speaker on June 10.
- UAMS Researchers Receive National Cancer Institute Grants Totaling More Than $540,000
LITTLE ROCK — Two researchers at the University of Arkansas for Medical Sciences (UAMS) have received research grants for pancreatic cancer and multiple myeloma, a cancer of the bone marrow.
- UAMS Researchers Receive National Cancer Institute Grants Totaling More Than $540,000
LITTLE ROCK — Two researchers at the University of Arkansas for Medical Sciences (UAMS) have received research grants for pancreatic cancer and multiple myeloma, a cancer of the bone marrow.
- UAMS Researchers Receive National Cancer Institute Grants Totaling More Than $540,000
LITTLE ROCK — Two researchers at the University of Arkansas for Medical Sciences (UAMS) have received research grants for pancreatic cancer and multiple myeloma, a cancer of the bone marrow.
- UAMS Researchers Receive National Cancer Institute Grants Totaling More Than $540,000
LITTLE ROCK — Two researchers at the University of Arkansas for Medical Sciences (UAMS) have received research grants for pancreatic cancer and multiple myeloma, a cancer of the bone marrow.
- UAMS Researchers Receive National Cancer Institute Grants Totaling More Than $540,000
LITTLE ROCK — Two researchers at the University of Arkansas for Medical Sciences (UAMS) have received research grants for pancreatic cancer and multiple myeloma, a cancer of the bone marrow.
- UAMS Study Finds Genetic Subtypes of Myeloma, Hope for Targeted Treatments
LITTLE ROCK – A genetic analysis of more than 400 patients with multiple myeloma, a cancer of the bone marrow, identified seven subtypes of the disease that had a bearing on a patient’s prognosis and offered the potential for targeted treatments, reported a team of researchers from the University of Arkansas for Medical Sciences (UAMS) in the September issue of the journal Blood.
- UAMS Study Finds Genetic Subtypes of Myeloma, Hope for Targeted Treatments
LITTLE ROCK – A genetic analysis of more than 400 patients with multiple myeloma, a cancer of the bone marrow, identified seven subtypes of the disease that had a bearing on a patient’s prognosis and offered the potential for targeted treatments, reported a team of researchers from the University of Arkansas for Medical Sciences (UAMS) in the September issue of the journal Blood.
- UAMS Study Finds Genetic Subtypes of Myeloma, Hope for Targeted Treatments
LITTLE ROCK – A genetic analysis of more than 400 patients with multiple myeloma, a cancer of the bone marrow, identified seven subtypes of the disease that had a bearing on a patient’s prognosis and offered the potential for targeted treatments, reported a team of researchers from the University of Arkansas for Medical Sciences (UAMS) in the September issue of the journal Blood.
- UAMS Researcher Receives $913,000 Grant From American Cancer Society to Study HPV Virus
LITTLE ROCK — A researcher at the University of Arkansas for Medical Sciences (UAMS) has received a grant of $913,000 from the American Cancer Society to study how the immune system of some women spontaneously clears the body of human papilloma virus (HPV).
- UAMS Researcher Receives $913,000 Grant From American Cancer Society to Study HPV Virus
LITTLE ROCK — A researcher at the University of Arkansas for Medical Sciences (UAMS) has received a grant of $913,000 from the American Cancer Society to study how the immune system of some women spontaneously clears the body of human papilloma virus (HPV).
- UAMS Researcher Receives $913,000 Grant From American Cancer Society to Study HPV Virus
LITTLE ROCK — A researcher at the University of Arkansas for Medical Sciences (UAMS) has received a grant of $913,000 from the American Cancer Society to study how the immune system of some women spontaneously clears the body of human papilloma virus (HPV).
- Annual Symposium Held, New Faculty Member Named
OCT. 4, 2006 | In July, the Arkansas Cancer Research Center’s (ACRC) Partners in Research program held its annual symposium.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Gray’s Anomaly: A Source of Empowerment
Feb. 8, 2012 | “I’ll trim it so it’s not so bulky,” James Y. Suen, M.D., said as he folded, then snipped a tiny edge of gauze off before he placed it on his patient’s right jaw. He has cared for 23-year-old Jasmine Gray ever since she was 11 when she traveled from Memphis, Tenn. to see him after first being misdiagnosed.
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Code Moo Now Open
Code Moo Now Open
- Code Moo Now Open
Code Moo Now Open
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
|
JUNE 13, 2005 | The Arkansas Cancer Research Center (ACRC) at the University of Arkansas for Medical Sciences (UAMS)held a “show and tell” for scientists May 20, but it wasn’t anything close to the ones from elementary school.
The first ACRC Research Presentation Day provided a forum for UAMS basic scientists – those who conduct research in laboratories, and clinical scientists -- those who conduct research by studying reactions in people, to share their cutting-edge research findings and answer questions. The event was open to researchers, physicians, students and others on the UAMS campus.
“The ACRC Research Presentation Day accomplished exactly what we set out to do,” said James Y. Suen, M.D., director of the ACRC and professor and chairman of the Otolaryngology/Head and Neck Surgery Department in the UAMS College of Medicine. “While our scientists share thoughts and ideas informally within their research areas, and share their work very formally through journal articles and presentations around the country, we needed a middle ground to allow them to collaborate with their colleagues and the clinicians here at UAMS. “
Larry J. Suva, Ph.D., director of the Center for Orthopaedic Research and associate professor in the Departments of Orthopaedic Surgery and Physiology and Biophysics in the UAMS College of Medicine, said the event was a major step forward for improving interactions between clinical and basic researchers on the campus.
“The ACRC continues to be a leader on campus in the development of translational research efforts, as laid out in the NIH road map,” he said.
Suva said the opportunity for basic scientists and clinicians to interact and discuss ongoing efforts, as well as identify areas of synergy and collaboration is a “win-win” for the faculty and the ACRC.
“I hope that there will be many more opportunities to continue with this effort and hope that the campus as a whole will become more actively involved in disseminating the great work that is done on a day-to-day basis at UAMS and the ACRC,” he said.
Links on This Page
Arkansas Cancer Research Center: http://www.acrc.uams.edu/
UAMS Cancer Research: http://www.acrc.uams.edu/cancer%5Fresearch/
© 2004 University of Arkansas for Medical Sciences (UAMS). A single copy of these materials may be reprinted for noncommercial personal use only. “UAMS,” “UAMS Medical Center,” “UAMS Online,” “UAMS Today,” “UAMS Update,” “uams.edu,” and “Here’s to Your Health” are marks of UAMS.
|